Related Experiment Video
Updated: Jun 23, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
A Prediction Rule for Occurrence of Chronic Thromboembolic Disease After Acute Pulmonary Embolism
1Department of Pulmonary and Critical Care Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Insights
A new Prediction Rule for CTED (PRC) score helps predict chronic thromboembolic disease (CTED) after acute pulmonary embolism (PE) treatment. This tool aids in identifying patients at risk for CTED following anticoagulation therapy.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Clinical Prediction Models
Background:
- Chronic thromboembolic disease (CTED) can occur despite standard anticoagulation for acute pulmonary embolism (PE).
- No validated scoring system currently exists to predict CTED development post-PE treatment.
Purpose of the Study:
- To develop and validate a prediction score for identifying patients at risk of CTED after acute PE.
- To provide a tool for risk stratification in patients treated for acute PE.
Main Methods:
- A Prediction Rule for CTED (PRC) score was developed in a cohort of 1,124 patients and validated in a separate cohort of 211 patients.
- Both original and simplified versions of the PRC score were evaluated using various performance metrics.
Main Results:
- The PRC score incorporates 10 risk factors including active cancer, autoimmune diseases, obesity, immobility, elevated D-dimer, PE with DVT, prior VTE, non-VTE thromboembolism, thrombophilia, and unprovoked VTE.
- In validation, the original PRC score demonstrated high sensitivity (86.3%) and specificity (76.3%) with a C-index of 0.815, outperforming the DASH score.
- The simplified PRC score also showed strong predictive performance, indicating its clinical utility.
Conclusions:
- The developed Prediction Rule for CTED (PRC) score effectively predicts the likelihood of CTED occurrence.
- The PRC score can aid clinicians in managing patients with acute PE by identifying those at higher risk for developing CTED.
Background:
Occurrence of chronic thromboembolic disease (CTED) after 3 or 6 months of standard and effective anticoagulation is not uncommon in patients with acute pulmonary embolism (PE). To date, there has been no scoring model for the prediction of CTED occurrence.
Methods:
A Prediction Rule for CTED (PRC) was established in the establishment cohort (n=1,124) and then validated in the validation cohort (n=211). Both original and simplified versions of the PRC score were provided by using different scoring and cut-offs.
Results:
The PRC score included 10 items: active cancer (3.641; 2.338-4.944; p<0.001), autoimmune diseases (2.218; 1.545-2.891; p=0.001), body mass index >30 kg/m2 (2.186; 1.573-2.799; p=0.001), chronic immobility (2.135; 1.741-2.529; p=0.001), D-dimer >2,000 ng/mL (1.618; 1.274-1.962; p=0.005), PE with deep vein thrombosis (3.199; 2.356-4.042; p<0.001), previous venous thromboembolism (VTE) history (5.268; 3.472-7.064; p<0.001), thromboembolism besides VTE (4.954; 3.150-6.758; p<0.001), thrombophilia (3.438; 2.573-4.303; p<0.001), and unprovoked VTE (2.227; 1.471-2.983; p=0.001). In the establishment cohort, the sensitivity, specificity, Youden index (YI), and C-index were 85.5%, 79.7%, 0.652, and 0.821 (0.732-0.909) when using the original PRC score, whereas they were 87.9%, 74.6%, 0.625, and 0.807 (0.718-0.897) when using the simplified one, respectively (Kappa coefficient 0.819, p-value of McNemar's test 0.786). In the validation cohort, the sensitivity, specificity, YI, and C-index were 86.3%, 76.3%, 0.626, and 0.815 (0.707-0.923) when using the original PRC score, whereas they were 85.0%, 78.6%, 0.636, and 0.818 (0.725-0.911) when using the simplified one, respectively (Kappa coefficient 0.912, p-value of McNemar's test 0.937); both were better than that of the DASH score (72.5%, 69.5%, 0.420, and 0.621 [0.532-0.710]).
Conclusions:
A prediction score for CTED occurrence, termed PRC, predicted the likelihood of CTED occurrence after 3 or 6 months of standard anticoagulation in hospitalised patients with a diagnosis of acute PE.
More Related Videos
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

